Borcherding S M, Stevens R, Nicholas R A, Corley C R, Self T
Department of Medical Affairs, Regulatory and Clinical Development, Procter & Gamble Co, Cincinnati, Ohio, USA.
J Fam Pract. 1996 Jan;42(1):69-78.
A review of the literature on quinolones reveals numerous clinically relevant points regarding indications, dosing considerations, and drug interactions. Quinolones are useful in the treatment of several infectious diseases. Unfortunately, indiscriminate use of these valuable antimicrobials has resulted in increased patterns of resistance. It is important to consider carefully the site of infection and the potential pathogens in each patient before dosing. Quinolones have excellent oral absorption, with peak serum concentrations approaching those achieved with intravenous administration. When prescribing quinolones, the dose should be based on estimated creatinine clearance. Quinolones are associated with several clinically significant drug interactions. Some of these agents are well-documented inhibitors of hepatic metabolism of theophylline, caffeine, and warfarin. It has been well documented that divalent and trivalent cations in antacids, sucralfate, and some other products significantly reduce the absorption of quinolones. Avoidance or proper management of these interactions is required to ensure optimal safety and efficacy.
对喹诺酮类药物的文献综述揭示了许多与适应症、剂量考量及药物相互作用相关的临床要点。喹诺酮类药物在多种传染病的治疗中很有用。不幸的是,这些有价值的抗菌药物的滥用导致了耐药性模式的增加。给药前仔细考虑每位患者的感染部位和潜在病原体很重要。喹诺酮类药物口服吸收良好,血清峰值浓度接近静脉给药时达到的浓度。开具喹诺酮类药物处方时,剂量应基于估计的肌酐清除率。喹诺酮类药物与几种具有临床意义的药物相互作用有关。其中一些药物是茶碱、咖啡因和华法林肝脏代谢的充分记录的抑制剂。充分记录表明,抗酸剂、硫糖铝和其他一些产品中的二价和三价阳离子会显著降低喹诺酮类药物的吸收。需要避免或妥善处理这些相互作用,以确保最佳的安全性和疗效。